Analyst firms · Wolfe Research · DHR
Wolfe Research DHR price target and rating history
Danaher Corporation (DHR) · Industrials
Wolfe Research rates Danaher Corporation (DHR) Peer Perform with a $285 price target, as of its latest action on Jun 2, 2026. It has published 3 rating actions on DHR since December 2023, including 1 upgrade and 0 downgrades. Across 7 firms with a DHR price target in the last 12 months, the median target is $230.
- Current rating
- Peer Perform
- Price target
- $285
- Median target, all firms
- $230
- Actions on DHR
- 3
Every Wolfe Research rating on DHR
- Jun 2, 2026
- Oct 31, 2024
- Dec 13, 2023
How other firms rate DHR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| UBS | Buy | $250 | Sep 9, 2026 |
| Piper Sandler | Neutral | $200 | Jun 11, 2026 |
| DZ Bank | Buy | $210 | Jun 3, 2026 |
| Wolfe Research | Peer Perform | Jun 2, 2026 | |
| Citigroup | Buy | $230 | May 26, 2026 |
| RBC Capital Markets | Outperform | $200 | May 15, 2026 |
| Goldman Sachs | Buy | $265 | Dec 9, 2025 |
| Morgan Stanley | Overweight | $270 | Dec 2, 2025 |
Questions about Wolfe Research and DHR
- What is Wolfe Research's price target for DHR?
- Wolfe Research's latest stated price target for Danaher Corporation (DHR) is $285, from its action on Oct 31, 2024.
- What is Wolfe Research's rating on DHR?
- Wolfe Research rates DHR Peer Perform, a neutral rating, as of Jun 2, 2026.
- When did Wolfe Research last change its view on DHR?
- On Jun 2, 2026, Wolfe Research resumes coverage at Peer Perform.
- How does Wolfe Research's DHR target compare with other analysts?
- Across 7 firms with a DHR price target in the last 12 months, the median target is $230.
More DHR rating histories
- RBC Capital Markets5
- Goldman Sachs4
- Barclays6
- BofA Securities3
- Wells Fargo5
- Credit Suisse4
- The Benchmark Company3
All Wolfe Research ratingsDHR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.